ChargePoint Holdings, Inc.
CHPT remains a cash-burning, structurally low-margin EV charging operator whose recent squeeze has outrun what the business is actually earning, even after genuine operating improvement.
The stock has moved faster than the business. CHPT now trades at $9.89, after a 77.56% one-week jump and a 70.22% one-month move, even though the company just finished FY2026 with revenue of only $0.4B, down 7.7% YoY, and an operating margin of -58.8%. That is the core disconnect. Investors are paying up for signs of stabilization before CHPT has shown a path to durable profitability.
The improvement is real, but not enough to support the current price. Q4 revenue hit $109M, the high end of guidance, and non-GAAP gross margin reached a record 33%. Adjusted EBITDA improved to -$18M, and FY26 net cash usage ex-debt payment fell to $43M from $133M. Reliability also improved sharply, with stations down reduced to below 1%. Those are tangible operating gains, and they explain why the equity can squeeze hard when sentiment turns. But even after those gains, CHPT is still losing money heavily, inventory is still $215M, and management is guiding Q1 FY27 revenue down to $90M-$100M after the strong Q4. That is not yet a self-funding growth company.
The bear case depends on three things. First, valuation is not cheap enough for this risk. CHPT trades at 0.6x sales against a peer average of 0.4x, while its earnings are deeply negative and peer P/E context is irrelevant because CHPT has no earnings. Second, execution credibility is only partial. Management has improved margins and cash discipline, but it previously targeted adjusted EBITDA positivity by Q4 FY25 and did not get there. Third, the business model still needs product transition to do the heavy lifting. Management is clear that pricing will not drive margin gains. Improvement depends on Flex AC now and next-gen DC in 2H FY27, which adds launch and adoption risk.
What would change the view is straightforward. Sustained revenue growth above the current $90M-$100M quarterly guide, a visible reduction in inventory from $215M, and evidence that next-gen DC can compress EBITDA losses materially from -$18M without another reset in expectations. Until then, the recent rally looks more technical than fundamental.
Europe stays strong, Flex AC ramps well, next-gen DC launches on time in 2H FY27, and EBITDA losses shrink fast enough to sustain the post-earnings momentum.
Gross margin holds near current levels and cash burn improves, but revenue growth remains uneven and the stock rerates closer to the engine's $6.84 fair value.
Q1 lands near the low end of $90M-$100M, inventory stays near $215M, and the recent squeeze unwinds as investors refocus on subscale revenue and persistent EBITDA losses.
Quant call (SELL) diverges from analyst consensus (Hold: 0 buy / 5 hold / 0 sell) — resolve explicitly.
We don't buy stocks where they are, we buy them where they're going.
Forward earnings power is still the problem. There is no meaningful forward P/E anchor because CHPT remains deeply loss-making, and even the latest quarter produced -$18M of adjusted EBITDA on $109M of revenue, so the market is still valuing hope, not earnings. The moat today is mostly software, installed-base relationships, and network reliability, but over the next 3-5 years that moat looks vulnerable if hardware becomes more modular and AI mainly benefits fleet routing, uptime prediction, and service optimization across the industry rather than only at ChargePoint. Regulation helps demand at the margin, especially with an active NEVI pipeline, but it does not fix the core issue that margin improvement still depends on 2H product ramps and Europe execution. AI is more incremental than transformational here, so the rating leans on weak forward earnings conversion, not on EV charging demand disappearing.
- Valuation disconnect: engine price target $6.84 versus current $9.89, implying -30.8% downside, with the method blend at $5.59 on P/S and $9.65 on quality-adjusted value.
- Profitability remains far from self-funding: FY2026 operating margin was -58.8%, net margin -64.4%, and Q4 adjusted EBITDA was still -$18M on $109M of revenue.
- Setup is crowded after the squeeze: the stock is -21.6% from its $12.61 52-week high but still 70.22% above one month ago, with 25.31% short interest and spot above the $8.91 zero-gamma level.
- Q4 FY26 revenue reached $109M, the high end of guidance, up 7% y/y and 3% q/q, showing the business can still grow in pockets despite a weak full-year result.
- Non-GAAP gross margin hit a record 33%, up from 24% in the 2025 Q1 period, helped by subscription mix and cost control, which is real evidence that unit economics are improving.
- Cash discipline improved meaningfully, with FY26 net cash usage ex-debt payment down to $43M from $133M, reducing near-term financing pressure.
- Operational reliability improved sharply, with stations down cut by more than half to below 1%, while Europe reached its highest revenue mix since going public and management sees better-margin product ramps in 2H FY27.
- FY2026 revenue fell 7.7% YoY to $0.4B, which is a poor backdrop for a company still posting a -58.8% operating margin and -9.41 EPS.
- Q1 FY27 guidance of $90M-$100M implies a sequential decline of roughly 8% at the midpoint from Q4's $109M, and management explicitly called for a 5%-15% seasonal step-down.
- Inventory remains heavy at $215M, more than two quarters of Q4 revenue, and management said reductions will be only gradual as prior commitments roll off.
- The track record on guidance is uneven: CHPT missed EPS by -2300.0% in 2025-06-04, -22.4% in 2025-09-03, and -78.1% in 2026-03-04, which limits confidence in another 2H-weighted recovery story.
| Metric | Value | Context |
|---|---|---|
| Current price | $9.89 | Used against the engine target and recent squeeze setup |
| Price target | $6.84 | Ground-truth target, -30.8% versus current, basis sales_quality_blend |
| Method blend | P/S $5.59, Quality-adjusted $9.65 | Explains why downside is meaningful but not extreme |
| FY2026 revenue | $0.4B | -7.7% YoY, weak base for a recovery narrative |
| FY2026 EPS | $-9.41 | -90.8% YoY, no useful earnings multiple support |
| FY2026 operating margin | -58.8% | Improved from -60.7% prior year, but still deeply negative |
| FY2026 net margin | -64.4% | Shows equity value still rests on future, not present, earnings power |
| Valuation | P/S 0.6x | Above peer average 0.4x despite weaker profitability |
| Q4 FY26 revenue / EBITDA | $109M / -$18M | Revenue hit high end of guide, EBITDA margin -16.5% |
| Q1 FY27 revenue guide | $90M-$100M | Implies a 5%-15% sequential seasonal decline versus Q4 |
| Inventory | $215M | Still elevated, with only gradual reduction expected in FY27 |
| 52-week position | $4.44-$12.61 | Current price is -21.6% from high and 52.6% above the $6.48 200-day average |
The biggest risk to a bearish view is that new products lift margins faster than expected, because management says next-gen DC will enter production in 2H FY27 with a substantially better profile after Q4 gross margin already reached 33%.
The next catalyst is earnings on December 3, 2026, where investors need to see Q1 revenue land within $90M-$100M, inventory fall from $215M, and evidence that Flex AC and next-gen DC are translating into better EBITDA, not just better rhetoric.
Positioning is part of the story here, and it cuts both ways. Short interest is 25.31%, or 5,757,348 shares, with 4.7 days-to-cover, which helps explain the 77.56% one-week move and raises squeeze risk against any bearish call. But spot at $9.89 is also above the $8.91 zero-gamma level in a positive GEX regime, so the technical support from dealer positioning can fade quickly if fundamentals do not validate the move. Institutional ownership data are clearly distorted at 285.0% for the top three holders, so it should not be read as a conventional sponsorship signal.
Management commentary implies hardware remains margin-constraining, while subscription efficiency helped lift non-GAAP gross margin to 33%.
Europe delivered robust growth and reached its highest revenue mix since going public, making it the clearest geographic bright spot.
The NEVI pipeline on obligated funds remains active through this year and potentially next year, but timing still depends on project readiness and installation cycles.
ChargePoint posted a solid Q4, but Q1 guidance implies a seasonal step-down.
Execution has improved, but credibility is still mixed. On the positive side, management said in the 2025 Q1 call, "We are committed to being adjusted EBITDA positive in the fourth quarter of this year," and that target was missed by a wide margin, because the latest reported Q4 FY26 adjusted EBITDA was still -$18M on $109M of revenue. That miss matters. At the same time, some promised building blocks did show up: non-GAAP gross margin improved from 24% in 2025 Q1 to 33% in 2026 Q4, OpEx discipline held, reliability improved to below 1% stations down, and cash usage ex-debt payment fell from $133M to $43M. The strategic direction has not changed much, because management is still leaning on a 2H recovery, product-led margin gains, and delayed demand conversion, much like the 2025 message that more revenue would come in the second half. That consistency helps, but the repeated dependence on future ramps, plus EPS misses of -2300.0%, -22.4%, and -78.1% across the last two years, keeps credibility below top tier.
We delivered a strong finish to fiscal 2026. Revenue for Q4 came in at the high end of our guidance range at $109 million, marking another quarter of year-over-year growth and execution above expectations.
After a strong fourth quarter, we expect first quarter revenue to be in the range of $90 million to $100 million, reflecting the typical seasonality we see in Q1.
And besides that, we're taking a prudent approach given the current macro environment. However, you noticed that our range does encompass a growth scenario year-over-year.
And then we've got our next-gen DC product, which has substantially better margin profile than our current DC architecture. And that will be ramping into production in the second half of this year, and we're very optimistic about the prospects for that product.
And then I think the acceleration on improvement in all 3 of those, particularly growth in gross margin, will be stronger in the second half as we introduce these new products, and we really take advantage of the favorable macro conditions in Europe with a whole suite of new products that we weren't selling into those segments before because we did not have a product offering.
The real moat is narrower than the EV charging narrative suggests. CHPT has value in its installed base, software layer, subscription economics, and improving reliability, with stations down now below 1%, which matters to fleets and commercial site hosts. The weak point is durability: if charger hardware standardizes and procurement shifts toward lowest-cost compliant platforms, the defensible profit pool sits in software and services, and CHPT has not yet shown that those strengths can carry the whole company to sustainable profits.
Capital allocation has turned more disciplined, which is one of the few clear positives. FY26 net cash usage ex-debt payment improved to $43M from $133M, OpEx was kept essentially flat in the latest quarter, and management is prioritizing inventory reduction from $215M rather than chasing growth at any cost. There are no buybacks, no dividends, and provided data show $0.0B for capex and buybacks, which is appropriate for a business still proving it can fund itself.
CHPT is a SELL. The company is improving, but the stock has already priced in too much of that improvement after a sharp squeeze, while the fundamentals still show declining FY2026 revenue, -58.8% operating margin, and a guided seasonal slowdown into Q1 FY27. The right question is not whether ChargePoint is better than it was a year ago, because it is. The question is whether that better business supports $9.89 today, and the answer is no. A move to neutral would require cleaner proof of sustained growth, materially lower inventory, and a credible path from -$18M quarterly EBITDA toward breakeven.
≣ Full research note tap to expand
Executive Summary
SELL, Medium conviction. CHPT rates a SELL at Medium conviction. The company has improved gross margin to 33% and sharply reduced cash usage, but revenue is still only $0.4B, down 7.7% YoY, operating margin is still -58.8%, and Q1 FY27 guidance of $90M-$100M points to another seasonal step-down after a strong Q4. At $9.89, the stock sits 52.6% above its 200-day average after a 77.56% one-week spike, while the quantitative price target is $6.84, or -30.8% downside.
Investment Thesis
The stock has moved faster than the business. CHPT now trades at $9.89, after a 77.56% one-week jump and a 70.22% one-month move, even though the company just finished FY2026 with revenue of only $0.4B, down 7.7% YoY, and an operating margin of -58.8%. That is the core disconnect. Investors are paying up for signs of stabilization before CHPT has shown a path to durable profitability.
The improvement is real, but not enough to support the current price. Q4 revenue hit $109M, the high end of guidance, and non-GAAP gross margin reached a record 33%. Adjusted EBITDA improved to -$18M, and FY26 net cash usage ex-debt payment fell to $43M from $133M. Reliability also improved sharply, with stations down reduced to below 1%. Those are tangible operating gains, and they explain why the equity can squeeze hard when sentiment turns. But even after those gains, CHPT is still losing money heavily, inventory is still $215M, and management is guiding Q1 FY27 revenue down to $90M-$100M after the strong Q4. That is not yet a self-funding growth company.
The bear case depends on three things. First, valuation is not cheap enough for this risk. CHPT trades at 0.6x sales against a peer average of 0.4x, while its earnings are deeply negative and peer P/E context is irrelevant because CHPT has no earnings. Second, execution credibility is only partial. Management has improved margins and cash discipline, but it previously targeted adjusted EBITDA positivity by Q4 FY25 and did not get there. Third, the business model still needs product transition to do the heavy lifting. Management is clear that pricing will not drive margin gains. Improvement depends on Flex AC now and next-gen DC in 2H FY27, which adds launch and adoption risk.
What would change the view is straightforward. Sustained revenue growth above the current $90M-$100M quarterly guide, a visible reduction in inventory from $215M, and evidence that next-gen DC can compress EBITDA losses materially from -$18M without another reset in expectations. Until then, the recent rally looks more technical than fundamental.
Key Metrics
| Metric | Value | Context |
|---|---|---|
| Current price | $9.89 | Used against the engine target and recent squeeze setup |
| Price target | $6.84 | Ground-truth target, -30.8% versus current, basis sales_quality_blend |
| Method blend | P/S $5.59, Quality-adjusted $9.65 | Explains why downside is meaningful but not extreme |
| FY2026 revenue | $0.4B | -7.7% YoY, weak base for a recovery narrative |
| FY2026 EPS | $-9.41 | -90.8% YoY, no useful earnings multiple support |
| FY2026 operating margin | -58.8% | Improved from -60.7% prior year, but still deeply negative |
| FY2026 net margin | -64.4% | Shows equity value still rests on future, not present, earnings power |
| Valuation | P/S 0.6x | Above peer average 0.4x despite weaker profitability |
| Q4 FY26 revenue / EBITDA | $109M / -$18M | Revenue hit high end of guide, EBITDA margin -16.5% |
| Q1 FY27 revenue guide | $90M-$100M | Implies a 5%-15% sequential seasonal decline versus Q4 |
| Inventory | $215M | Still elevated, with only gradual reduction expected in FY27 |
| 52-week position | $4.44-$12.61 | Current price is -21.6% from high and 52.6% above the $6.48 200-day average |
Financial Strength
The balance sheet is not broken, but it is not comfortable either. A 1.15 current ratio and $0.2B of total debt leave limited room for another operating stumble, especially because the company is still posting large accounting losses. The good news is that cash discipline has improved sharply, with FY26 net cash usage ex-debt payment down to $43M from $133M, and Q4 EBITDA margin improved to -16.5% from -19.3% in Q3. The bad news is that inventory at $215M is still too high for a company with quarterly revenue around $100M, so balance-sheet repair still depends on better sell-through and cleaner product transitions.
Competitive Position
The real moat is narrower than the EV charging narrative suggests. CHPT has value in its installed base, software layer, subscription economics, and improving reliability, with stations down now below 1%, which matters to fleets and commercial site hosts. The weak point is durability: if charger hardware standardizes and procurement shifts toward lowest-cost compliant platforms, the defensible profit pool sits in software and services, and CHPT has not yet shown that those strengths can carry the whole company to sustainable profits.
Management & Guidance
Management guided Q1 FY27 revenue to $90M-$100M, with non-GAAP OpEx roughly flat and inventory expected to decline gradually through FY27. The message is prudent rather than promotional, and it still leans on a stronger second half as Flex AC ramps and next-gen DC enters production. That is plausible, especially after Q4 gross margin reached 33%, but credibility is constrained by a mixed earnings record and the earlier failure to achieve the promised adjusted EBITDA-positive Q4 FY25. The guidance deserves some credit for realism, but not a premium valuation.
Segment Analysis
- Product mix (Not disclosed in the provided data): Management commentary implies hardware remains margin-constraining, while subscription efficiency helped lift non-GAAP gross margin to 33%.
- Europe (Not disclosed in the provided data): Europe delivered robust growth and reached its highest revenue mix since going public, making it the clearest geographic bright spot.
- North America / NEVI-linked demand (Not disclosed in the provided data): The NEVI pipeline on obligated funds remains active through this year and potentially next year, but timing still depends on project readiness and installation cycles.
Capital Allocation
Capital allocation has turned more disciplined, which is one of the few clear positives. FY26 net cash usage ex-debt payment improved to $43M from $133M, OpEx was kept essentially flat in the latest quarter, and management is prioritizing inventory reduction from $215M rather than chasing growth at any cost. There are no buybacks, no dividends, and provided data show $0.0B for capex and buybacks, which is appropriate for a business still proving it can fund itself.
Management Execution & Track Record
Execution has improved, but credibility is still mixed. On the positive side, management said in the 2025 Q1 call, "We are committed to being adjusted EBITDA positive in the fourth quarter of this year," and that target was missed by a wide margin, because the latest reported Q4 FY26 adjusted EBITDA was still -$18M on $109M of revenue. That miss matters. At the same time, some promised building blocks did show up: non-GAAP gross margin improved from 24% in 2025 Q1 to 33% in 2026 Q4, OpEx discipline held, reliability improved to below 1% stations down, and cash usage ex-debt payment fell from $133M to $43M. The strategic direction has not changed much, because management is still leaning on a 2H recovery, product-led margin gains, and delayed demand conversion, much like the 2025 message that more revenue would come in the second half. That consistency helps, but the repeated dependence on future ramps, plus EPS misses of -2300.0%, -22.4%, and -78.1% across the last two years, keeps credibility below top tier.
Positioning & Flows
Positioning is part of the story here, and it cuts both ways. Short interest is 25.31%, or 5,757,348 shares, with 4.7 days-to-cover, which helps explain the 77.56% one-week move and raises squeeze risk against any bearish call. But spot at $9.89 is also above the $8.91 zero-gamma level in a positive GEX regime, so the technical support from dealer positioning can fade quickly if fundamentals do not validate the move. Institutional ownership data are clearly distorted at 285.0% for the top three holders, so it should not be read as a conventional sponsorship signal.
Bull Case
- Q4 FY26 revenue reached $109M, the high end of guidance, up 7% y/y and 3% q/q, showing the business can still grow in pockets despite a weak full-year result.
- Non-GAAP gross margin hit a record 33%, up from 24% in the 2025 Q1 period, helped by subscription mix and cost control, which is real evidence that unit economics are improving.
- Cash discipline improved meaningfully, with FY26 net cash usage ex-debt payment down to $43M from $133M, reducing near-term financing pressure.
- Operational reliability improved sharply, with stations down cut by more than half to below 1%, while Europe reached its highest revenue mix since going public and management sees better-margin product ramps in 2H FY27.
Bear Case
- FY2026 revenue fell 7.7% YoY to $0.4B, which is a poor backdrop for a company still posting a -58.8% operating margin and -9.41 EPS.
- Q1 FY27 guidance of $90M-$100M implies a sequential decline of roughly 8% at the midpoint from Q4's $109M, and management explicitly called for a 5%-15% seasonal step-down.
- Inventory remains heavy at $215M, more than two quarters of Q4 revenue, and management said reductions will be only gradual as prior commitments roll off.
- The track record on guidance is uneven: CHPT missed EPS by -2300.0% in 2025-06-04, -22.4% in 2025-09-03, and -78.1% in 2026-03-04, which limits confidence in another 2H-weighted recovery story.
Valuation & Price Target
Engine price target $6.84 (-30.8% vs current), Medium confidence.
- P/S Multiple: $5.59 (45% weight)
- Quality-adjusted: $9.65 (20% weight)
This call aligns with the quant baseline: SELL with Medium conviction. The quantitative target of $6.84 fits the fundamental picture, because CHPT trades at 0.6x sales versus peer average 0.4x despite FY2026 revenue declining 7.7%, operating margin sitting at -58.8%, and only modest near-term guidance of $90M-$100M for Q1 FY27. The quality-adjusted method at $9.65 explains why conviction is not high, since gross margin, cash burn, and reliability are genuinely getting better, but the business still lacks visible earnings power. Sell-side consensus sits at Hold from 5 firms, but that is low-signal context and does not outweigh the gap between the current stock price and what the income statement supports.
Risk Assessment
Risk score 57/100 (Moderate). The biggest risk to a bearish view is that new products lift margins faster than expected, because management says next-gen DC will enter production in 2H FY27 with a substantially better profile after Q4 gross margin already reached 33%.
The Bottom Line
CHPT is a SELL. The company is improving, but the stock has already priced in too much of that improvement after a sharp squeeze, while the fundamentals still show declining FY2026 revenue, -58.8% operating margin, and a guided seasonal slowdown into Q1 FY27. The right question is not whether ChargePoint is better than it was a year ago, because it is. The question is whether that better business supports $9.89 today, and the answer is no. A move to neutral would require cleaner proof of sustained growth, materially lower inventory, and a credible path from -$18M quarterly EBITDA toward breakeven.
Go deeper in the app
Live charts, options analytics, the full earnings-call breakdown, price alerts, and every other stock — updated in real time.
Get Tickr